The West of England AHSN is providing a series of 30 minute education webinars on the benefits of FeNO testing in primary care.
About this event
This virtual session (which will be repeated on three dates) is available to sites within the West of England who are considering implementing FeNO Testing and will be delivered by primary care GPs and nurses from the region.
FeNO (fractional exhaled nitric oxide) is a point of care test to measure type two inflammation in airways, which augments and supports the accuracy of asthma diagnosis. The aim of this innovation is to improve patient care and outcomes by more effective diagnosis of patients suspected of having asthma.
The webinar will focus on the benefits of FeNO testing in primary care and what we are trying to achieve by rolling this out. How to interpret the results of the test and signposting to further resources will also be included.
It is suitable for practice managers and healthcare professionals involved in the diagnosis and management of patients with asthma.